SIMPLEr not to test implantable cardioverter defibrillators?

SIMPLEr not to test implantable cardioverter defibrillators?

Despite this being an approved and commonly practised strategy, clinicians have always been concerned about the risk-to-benefit ratio and its questionable effect on long-term clinical outcomes. In The Lancet, Jeff Healey and colleagues report the results from their Shockless IMPLant Evaluation (SIMP...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 2015-02, Vol.385 (9970), p.753-755
Hauptverfasser: Singh, Jagmeet P, Holzmeister, Johannes
Format: Artikel
Sprache:eng
Schlagworte:
Arrhythmias, Cardiac - therapy
Cardiac arrhythmia
Defibrillators
Defibrillators, Implantable
Electric Countershock - methods
Female
Heart attacks
Humans
Internal Medicine
Male
Postoperative Complications - etiology
Prosthesis Implantation - methods
Transplants & implants
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Despite this being an approved and commonly practised strategy, clinicians have always been concerned about the risk-to-benefit ratio and its questionable effect on long-term clinical outcomes. In The Lancet, Jeff Healey and colleagues report the results from their Shockless IMPLant Evaluation (SIMPLE) study that compared the efficacy and safety of ICD implantation with and without defibrillator testing.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(15)60242-2